StockData
ENDRA Life Sciences Inc. logo

ENDRA Life Sciences Inc. (NDRA) stock

NDRANasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 6/30
$4.04+0.12 (+2.93%)

Close on Nov 18, 2026Market cap $6.05MP/E –Yield –

Earnings

ENDRA Life Sciences's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
–
Not yet scheduled
Revenue, Q1 FY2025
–
EPS, Q1 FY2025
-$1.86
-$0.26 a year earlier
Latest guidance
None
No outlook given in releases

Quarterly results

Revenue and earnings per share from each of ENDRA Life Sciences's earnings releases, newest first

QuarterReportedRevenueYoYEPSSource
Q2 FY2026ended Jun 30, 2026Aug 17, 2026after the close–––Release
Q4 FY2025ended Dec 31, 2025Mar 31, 2026after the close–––Release
Q2 FY2025ended Jun 30, 2025Jul 9, 2025after the close–––Release
Q1 FY2025ended Mar 31, 2025May 15, 2025after the close––-$1.86Release
Q4 FY2024ended Dec 31, 2024Mar 31, 2025before the open–––Release
Q3 FY2024ended Sep 30, 2024Nov 15, 2024after the close––-$9.54Release
Q2 FY2024ended Jun 30, 2024Aug 23, 2024after the close––-$0.08Release
Q1 FY2024ended Mar 31, 2024May 14, 2024after the close––-$0.26Release
Q4 FY2023ended Dec 31, 2023Mar 28, 2024after the close––$0.17Release
Q3 FY2023ended Sep 30, 2023Nov 14, 2023after the close––-$0.40Release
Q2 FY2023ended Jun 30, 2023Aug 14, 2023after the close––-$0.43Release
Q1 FY2023ended Mar 31, 2023May 15, 2023after the close––-$0.93Release

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Guidance

ENDRA Life Sciences has not given guidance in its releases

Many companies give their outlook only on the conference call or not at all. When ENDRA Life Sciences puts a forecast in an earnings release, it is listed here with the exact sentence.

Press releases

Releases ENDRA Life Sciences filed with the SEC as exhibits to Form 8-K or 6-K

  1. Results
  2. Results
  3. Update
  4. Update
  5. Results
  6. Update
  7. Update
  8. Update
  9. Update
  10. Results
  11. Results
  12. Results
  13. Results
  14. Update
  15. Results

See a number that looks wrong?